A relatively high proportion of patients develop ILD in some subtypes of CTD. Is this risk adequately appreciated among clinicians managing the underlying autoimmune condition?
A relatively high proportion of patients develop ILD in some subtypes of CTD. Is this risk adequately appreciated among clinicians managing the underlying autoimmune condition?